About
Tevard Biosciences develops tRNA-based gene therapies aimed at treating rare genetic diseases caused by nonsense mutations, including Dravet syndrome, dilated cardiomyopathy, and Duchenne muscular dystrophy.
Explore Tevard Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.